Boiron SA

BOI

Company Profile

  • Business description

    Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

  • Contact

    2, Avenue de l’Ouest Lyonnais No. 039
    Messimy69510
    FRA

    T: +33 478456100

    E: [email protected]

    http://www.boiron.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,788

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,369.304.70-0.06%
CAC 407,709.5218.41-0.24%
DAX 4023,242.66101.88-0.44%
Dow JONES (US)41,218.8398.60-0.24%
FTSE 1008,609.8413.490.16%
HKSE22,665.13160.450.71%
NASDAQ17,844.24133.49-0.74%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,421.090.16-0.00%
S&P 5005,650.3836.29-0.64%
S&P/ASX 2008,151.406.40-0.08%
SSE Composite Index3,316.1137.081.13%

Market Movers